In the News,
Question of The Week,
ImmunoGen Appoints Stuart A. Arbuckle to Board of Directors
Activist Alex Denner to Gain Board Control at Medicines Company
Shire Faces Criticism on CEO Pay Policy as Crunch Week Looms
Bevy of Scandals Expose Japan Inc's Corporate Governance Problem
Japan's Takeda Seals $62 Billion Takeover of Adderall Maker Shire
Allergan and Takeda May Fight Over Shire
Quotes about Takeda
This is a very exciting time for Takeda as we will broaden our hematology portfolio and transform our global solid tumor franchise through the addition of two innovative targeted therapies.
Takeda is buying Ariad Pharmaceuticals in a $5.2 billion Deal
I have followed Presage with interest through its partnership with Takeda during my tenure there, and I have always been particularly impressed with Presage's unique approach and its efficiency and effectiveness for discovering novel drug combinations.
Presage Biosciences Appoints Two New Directors
They have a different vision of what Takeda should become.
Takeda Pushes Back as Group Seeks to Stop $62 Billion Shire Deal